| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |